The Challenges, the Time and the Real Cost of Getting Biocidal Product Authorisation. An SME Perspective

A real company view of the complications and challenges of the approval process for Biocidal Products both in the UK and Europe. Where the main costs arise, decisions and risks that are associated and how can improvements be made in the process to encourage innovation